ANTICARDIOLIPIN - ANVISA Registration 80867150148
Access comprehensive regulatory information for ANTICARDIOLIPIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80867150148 and manufactured by SHENZHEN YHLO BIOTECH CO., LTD. The registration is held by BIOMOLECULAR TECHNOLOGY COMÉRCIO, IMPORTAÇÃO, EXPORTAÇÃO E DISTRIBUIÇÃO DE MATERIAIS MÉDICOS E LABORATORIAIS LTDA - EPP with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ORGENTEC DIAGNOSTIKA GMBH, PHADIA AB, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
80867150148
25351353886202337
07767477000146
Company Information
Dates and Status
Jul 03, 2023
VIGENTE
09/18/2025 19:00:01
ANTICARDIOLIPINA
Família MAGLUMI® IgM Anticardiolipina (CLIA)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
81504790422
Aug 26, 2024
ANTICARDIOLIPINA
Família MAGLUMI® IgG Anticardiolipina
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
81504790387
Jan 29, 2024
ANTICARDIOLIPINA
Familia iFlash-Cardiolipin IgM
SHENZHEN YHLO BIOTECH CO., LTD
80867150150
Jul 10, 2023
ANTICARDIOLIPINA
Família iFlash Cardiolipin IgG
SHENZHEN YHLO BIOTECH CO., LTD
80867150152
Jul 10, 2023
ANTICARDIOLIPINA
Família iFlash-Anti-Cardiolipin
SHENZHEN YHLO BIOTECH CO., LTD
80867150149
Jul 03, 2023

